ORIGINAL RESEARCH article

Front. Microbiol., 11 August 2026

Sec. Food Microbiology

Volume 17 - 2026 | https://doi.org/10.3389/fmicb.2026.1883400

Molecular epidemiology of mcr-1-harboring avian pathogenic Escherichia coli from diseased chickens in Shanxi, China (2021–2024)

  • 1. College of Veterinary Medicine, Shanxi Agricultural University, Taigu, China

  • 2. The Chinese Academy of Agricultural Sciences (CAAS), Shanghai Veterinary Research Institute, Shanghai, China

  • 3. Key Laboratory of Fujian Universities Preventive Veterinary Medicine and Biotechnology, Longyan University, Longyan, China

Abstract

Introduction:

The emergence of mcr-1-harboring avian pathogenic Escherichia coli (APEC) poses a significant One Health challenge due to its zoonotic potential and adverse effects on poultry production.

Methods:

A total of 50 mcr-1-positive APEC isolates were recovered from diseased chickens in Shanxi Province, China, between 2021 and 2024. All isolates were subjected to serotyping, phylogenetic grouping, antimicrobial susceptibility testing, detection of resistance and virulence-associated genes, and biofilm formation assessment.

Results:

Serotyping identified O18 (28%) and O78 (20%) as the predominant serotypes, with no O1 detected. Phylogenetic analysis showed that phylogroup A was most prevalent (32.0%), followed by B2 (12.0%), D (12.0%), and B1 (10.0%); the remaining isolates (34.0%) were untypeable. All isolates were multidrug-resistant (resistant to ≥3 drug classes), with universal resistance to tetracycline and trimethoprim-sulfamethoxazole, and over 85% resistance to kanamycin, amoxicillin, florfenicol, and chloramphenicol. The resistance genes tetA, blaTEM, aphA, and sul2, as well as the virulence genes ibeB and ompA, were detected in all isolates (100%). Biofilm formation was observed in 96% of the isolates, though its correlation with individual resistance or virulence genes was weak.

Discussion:

The findings demonstrate that mcr-1-positive APEC isolates in Shanxi Province exhibit high-level multidrug resistance, widespread virulence gene carriage, and strong biofilm-forming capacity, underscoring their potential public health risk through animal-to-human transmission. These data provide a baseline for local surveillance and highlight the need for enhanced antimicrobial stewardship in poultry production.)

1 Introduction

Avian pathogenic Escherichia coli (APEC) is an extraintestinal pathogenic E. coli (ExPEC) with a broad host range (Fu et al., 2023). Avian colibacillosis caused by APEC has persisted in poultry production for more than 50 years and remains one of the most important bacterial diseases in the industry (Johnson et al., 2022). This disease often leads to localized or systemic infections in poultry, including respiratory infections, septicemia, polyserositis, and cellulitis, resulting in substantial economic losses to the poultry industry (Yin et al., 2022). In addition, APEC poses a potential public health risk to humans, as some APEC strains are highly homologous to human ExPEC, share multiple virulence factors, exhibit close phylogenetic relationships, and may cause disease in mammals (Jamali et al., 2024; Wang et al., 2022). Moreover, most APEC strains harbor ColV or ColV-like plasmids that encode multiple virulence genes and have been shown to contribute to their pathogenicity in poultry (Habouria et al., 2019).

Antimicrobial resistance (AMR), particularly multidrug resistance (MDR) to multiple antibiotics, is recognized as one of the greatest global public health threats of the 21st century (Zhao et al., 2022). The large-scale and indiscriminate use of antibiotics in veterinary practice has contributed to the increasing prevalence of multidrug-resistant APEC strains (Hai et al., 2025; Seiffert et al., 2013). Moreover, E. coli can acquire AMR genes through various mobile genetic elements (MGEs), and these resistance determinants can further disseminate among humans, animals, and the environment via horizontal gene transfer (HGT) (Shoaib et al., 2025). Polymyxins are generally regarded as last-resort antibiotics for the treatment of infections caused by Gram-negative bacteria; however, their clinical effectiveness is increasingly compromised by the global spread of plasmid-mediated colistin resistance genes (mcr) (Nawaz et al., 2024; Nang et al., 2019). To date, ten mcr variants have been identified, among which mcr-1 is the most prevalent and the earliest discovered (Ramaloko and Osei Sekyere, 2022). The rapid evolution and dissemination of the mcr gene family pose a serious threat to global public health (Liang et al., 2025).

As one of the major virulence factors of APEC, biofilm formation enhances resistance to host immune defenses and improves bacterial survival in the environment (Hu et al., 2022). Biofilms are complex microbial communities characterized by a dynamic, adhesive, and protective extracellular matrix composed mainly of polysaccharides, proteins, and nucleic acids (Carradori et al., 2020). The presence of biofilms surrounding bacterial cells can partially or completely reduce the efficacy of antimicrobial agents, thereby increasing antibiotic tolerance and further contributing to the emergence and spread of AMR (Idrees et al., 2021). Therefore, epidemiological investigations supported by molecular approaches that assess antimicrobial resistance profiles, virulence-associated genes, resistance determinants, and biofilm-forming capacity of APEC are essential for the prevention and control of E. coli infections in poultry farms (Quaresma et al., 2022; Li et al., 2021).

This study aimed to systematically characterize the molecular epidemiological features of mcr-1-positive isolates obtained from 356 chickens suspected of colibacillosis in Shanxi Province, China, between 2021 and 2024, and to analyze the associations between biofilm-forming capacity and multiple related factors. These molecular epidemiological investigations are of great importance for controlling the emergence of multidrug-resistant APEC strains and for reducing the risk of antimicrobial resistance transmission from poultry to humans through the food chain.

2 Materials and methods

2.1 Isolation and identification of mcr-1-positive APEC

Between 2021 and 2024, a total of 356 chickens suspected of colibacillosis were collected from broiler farms in Shanxi Province, China. Samples were streaked onto eosin methylene blue (EMB) agar (Oxoid Company, Manchester, United Kingdom), and single colonies exhibiting a metallic green sheen were selected and inoculated into Luria–Bertani (LB) broth (Qingdao Haibo Biotechnology, China), followed by incubation at 37 °C overnight. Bacterial genomic DNA was extracted using a commercial genomic DNA extraction kit (Tiangen Biotech, China) according to the manufacturer’s instructions. The isolates were confirmed as E. coli by PCR amplification of the phoA gene using primers phoA-F/phoA-R (F: CGATTCTGGAAATGGCAAAAG; R: CGTGATCAGCGGTGACTATGAC), with a PCR reaction lacking template DNA included as a negative control. From the 356 samples, a total of 289 E. coli isolates were recovered. All 289 isolates were subsequently screened for the mcr-1 gene by PCR using primers mcr-1-F/mcr-1-R (F: CGGTCAGTCCGTTTGTTC; R: CTTGGTCGGTCTGTAGGG), yielding 50 mcr-1-positive strains (17.30% positivity rate among E. coli isolates). To ensure epidemiological independence, only one isolate per chickens was retained for further analysis. Bacterial genomic DNA was extracted using a commercial genomic DNA extraction kit (Tiangen Biotech, China) according to the manufacturer’s instructions. Detailed sampling site distribution and isolation rates are presented in Supplementary Table S1.

2.2 Serotyping analysis

Serotyping of APEC was performed according to the method described by Fancher et al. (2021). Serotype-specific primers (Supplementary Table S2) were used for PCR amplification with genomic DNA from the isolates as templates. Each PCR reaction mixture (20 μL) contained 10 μL of 2 × Es Taq MasterMix Dye, 7 μL of ddH2O, 1 μL of each forward and reverse primer, and 1 μL of DNA template. The PCR cycling conditions were as follows: initial denaturation at 98 °C for 1 min; 35 cycles of denaturation at 98 °C for 15 s, annealing at 55 °C for 15 s, and extension at 72 °C for 15 s; followed by a final extension at 72 °C for 10 min. All PCR products were analyzed by electrophoresis on 1.0% agarose gels (Sangon Biotech, China) to determine amplicon sizes, and the amplification results were recorded.

2.3 Phylogenetic grouping analysis

Phylogenetic grouping of E. coli isolates was determined according to the method described by Clermont et al. (2000), based on the presence or absence of the chuA and yjaA genes and the TspE4. C2 DNA fragment. PCR assays targeting these genetic markers were performed using genomic DNA from the isolates as templates, with primer sequences listed in Supplementary Table S3. Each PCR reaction (20 μL) consisted of 10 μL of 2 × Es Taq MasterMix Dye, 7 μL of ddH2O, 1 μL of each forward and reverse primer, and 1 μL of DNA template. The PCR cycling conditions were as follows: initial denaturation at 94 °C for 4 min; 30 cycles of denaturation at 94 °C for 4 min, annealing at 50–60 °C for 40 s, and extension at 72 °C for 1 min; followed by a final extension at 72 °C for 10 min. PCR products were analyzed by electrophoresis on 1.0% agarose gels, and amplicons of the expected size were purified and sequenced by Sangon Biotech. Sequence identity was confirmed by BLAST analysis (BLAST: Basic Local Alignment Search Tool).

2.4 Antimicrobial susceptibility testing

Antimicrobial susceptibility testing was performed using the disk diffusion (Kirby–Bauer) method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines (M100, 32nd edition, 2022). Escherichia coli ATCC 25922 was used as the quality control strain, with inhibition zone diameters verified to fall within the expected ranges specified by CLSI (Feng et al., 2023). Bacterial suspensions (approximately 1 × 107 CFU/mL) were evenly spread onto Mueller–Hinton (MH) agar (AOBOX Biotech, China) plates. After complete absorption, antimicrobial disks (Microbial Reagent Co., China) containing chloramphenicol (CAP, 30 μg), florfenicol (FFC, 30 μg), amoxicillin (AMX, 20 μg), ceftazidime (CAZ, 30 μg), enrofloxacin (ENFX, 10 μg), ofloxacin (OFX, 5 μg), tetracycline (TC, 30 μg), trimethoprim–sulfamethoxazole (SMZ-TMP, 19 μg), amikacin (AMK, 30 μg), and kanamycin (KAN, 30 μg) were placed on the agar surface using sterile forceps. Plates were incubated at 37 °C for 18 h, after which the diameters of inhibition zones were measured and recorded. Interpretation of susceptibility (susceptible, intermediate, or resistant) was based on the CLSI breakpoints for each antibiotic. All assays were performed in triplicate, and the mean inhibition zone diameters were used for subsequent analysis.

2.5 Detection of antimicrobial resistance genes

PCR assays were performed to detect five common classes of antimicrobial resistance genes in E. coli (Ngai et al., 2021), including tetracycline resistance genes (tetA), amphenicol resistance genes (cat1 and floR), β-lactam resistance genes (blaTEM and blaCTX-M), aminoglycoside resistance genes (strA and aphA), and sulfonamide resistance genes (sul1 and sul2). The primer sequences used for amplification are listed in Supplementary Table S4. The PCR reaction mixtures and cycling conditions were performed as described above.

2.6 Detection of virulence-associated genes

PCR assays were conducted to detect common virulence-associated genes in E. coli, including adhesin-related genes (aatA, papC, tsh, fimC, mat, and vat), iron acquisition–related genes (fyuA, iucD, and irp2), invasion-associated genes (ibeB, yijP, and ibeA), and serum resistance–associated genes (ompA, neuC, cva, iss, and iroN) (Kathayat et al., 2021; Thomrongsuwannakij et al., 2020). Gene-specific primers were designed for amplification, and the primer sequences are listed in Supplementary Table S5. Genomic DNA from the isolates was used as the template, and the PCR reaction mixtures and cycling conditions were performed as described above.

2.7 Biofilm formation assay

Biofilm formation by the isolates was assessed using the crystal violet staining method (Yin et al., 2022). Single colonies of APEC isolates were inoculated into tubes, and bacterial suspensions adjusted to an OD600 of 1.0 were diluted 1:100 with LB broth and dispensed into sterile 96-well microtiter plates (200 μL per well), with six replicate wells for each isolate. Plates were incubated statically at 37 °C for 24 h, with sterile LB broth and 1% lactose-supplemented LB broth included as blank controls. After incubation, the culture medium was discarded, and the wells were gently washed twice with phosphate-buffered saline (PBS). Following air drying, 200 μL of 0.1% (w/v) crystal violet (Coolaber, China) solution was added to each well and incubated at 37 °C for 30 min. The crystal violet solution was then removed, and the wells were washed twice with PBS, air-dried at room temperature, and treated with 200 μL of 95% ethanol to solubilize the bound dye at 37 °C for 10 min. The absorbance was measured at 595 nm using a microplate reader (ThermoFisher, United States), and the results were recorded and analyzed. Biofilm-forming ability was classified according to the criteria described by Li et al. (2021).

2.8 Statistical analysis

All experiments were independently repeated at least three times. Data are presented as the mean ± standard deviation (SD). Differences between groups were assessed using one-way analysis of variance (ANOVA). The linear correlation between two variables was evaluated with Pearson’s correlation coefficient (r). For invariant genes, the values were directly assigned as 0. For each gene–biofilm combination, the correlation coefficient was calculated, and the 95% confidence interval (CI) of r was estimated via nonparametric bootstrap resampling (1,000 iterations). To control the false positive risk arising from multiple comparisons, p-values were adjusted using the Benjamini–Hochberg false discovery rate (FDR) method. An adjusted p < 0.05 was considered statistically significant. Specifically, correlation strength was interpreted as follows: 0.5 ≤ |r| < 1.0, strong correlation; 0.3 ≤ |r| < 0.5, moderate correlation; 0.1 ≤ |r| < 0.3, weak correlation; and |r| < 0.1, no correlation. All statistical analyses were performed using GraphPad Prism (version 9.0) and R (version 4.5.2).

3 Results

3.1 Serotyping and phylogenetic analysis of mcr-1-positive isolates

PCR-based serotyping was performed to identify the O1, O2, O18, O78, and O145 serogroups among 50 mcr-1-positive isolates. The results showed that serogroup O18 was the most prevalent, with 14 isolates (28%), followed by O78 with 10 isolates (20%). Six isolates (12%) belonged to serogroup O145, and seven isolates (14%) were classified as O2. No isolates of serogroup O1 were detected. Among the 50 mcr-1-positive APEC isolates, 13 isolates (26%) could not be assigned to any of the tested serogroups (Figure 1A). To determine the phylogenetic distribution of the isolates, the presence of chuA, yjaA, and TspE4. C2 was examined. As shown in Figure 1B, phylogroup A was the most common, accounting for 32.0% (16/50) of the isolates. In contrast, phylogroups B1, B2, and D were less frequent, representing 10% (5/50), 12% (6/50), and 12% (6/50), respectively. In addition, 34% (17/50) of the mcr-1-positive isolates could not be assigned to the established E. coli phylogenetic group.

Figure 1

3.2 Antimicrobial resistance phenotypes and multidrug resistance profiles

Antimicrobial susceptibility testing showed that the 50 APEC isolates exhibited varying degrees of resistance to six classes of antibiotics, including amphenicols, β-lactams, quinolones, tetracyclines, sulfonamides, and aminoglycosides. All isolates were resistant to tetracycline and trimethoprim-sulfamethoxazole. High resistance rates were also observed for kanamycin (88%, 44/50), amoxicillin (94%, 47/50), florfenicol (88%, 44/50), and chloramphenicol (98%, 49/50). A lower resistance rate was detected for enrofloxacin (18%, 9/50). Only two isolates (4%) showed resistance to ceftazidime and ofloxacin. For amikacin, 46 isolates (92%) were susceptible, 4 isolates (8%) showed intermediate susceptibility, and none was resistant (Table 1). To further characterize the multidrug resistance profiles, isolates were grouped according to the number of antimicrobial classes to which they were resistant (Figure 2). The most prevalent pattern was resistance to six classes, observed in 80% (40/50) of the isolates. Resistance to five classes accounted for 10% (5/50), and resistance to four classes represented 4% (2/50). Only 2% (1/50) of the isolates showed resistance to three classes, and 4% (2/50) were resistant to fewer than three classes. Notably, 96% (48/50) of the isolates were classified as multidrug-resistant (resistant to o3 antimicrobial classes), underscoring the extensive antimicrobial resistance burden among mcr-1-positive APEC strains in this region.

Table 1

Antibiotics classAntibiotics nameNumber of strains/NumberPercentage of resistance
SensitivityIntermediateResistance
AmidesChloramphenicol104998.00%
Florfenicol244488.00%
β-lactamsAmoxicillin124794.00%
Ceftazidime47124.00%
QuinolonesEnrofloxacin041918.00%
Ofloxacin43524.00%
TetracyclinesTetracycline0050100.00%
Sulfonamidestrimethoprim-sulfamethoxazole0050100.00%
AminoglycosidesAmikacin46400.00%
Kanamycin154488.00%

Antimicrobial susceptibility testing results of mcr-1-positive strains.

Figure 2

3.3 Identification of antimicrobial resistance genes

To analyze antimicrobial resistance genes in the 50 mcr-1-positive isolates, PCR assays were performed for each strain. The tetracycline resistance gene tetA was detected in all isolates (100%, 50/50). Among amphenicol resistance genes, cat1 was not detected (0%, 0/50), whereas floR was present in 84% (42/50) of the isolates. For β-lactam resistance, blaTEM was detected in all isolates (100%, 50/50), while blaCTX-M was identified in 26% (13/50). The aminoglycoside resistance genes strA and aphA were detected in 84% (42/50) and 100% (50/50) of the isolates, respectively. The quinolone resistance gene qnrA was not detected (0%, 0/50). For sulfonamide resistance, sul1 and sul2 were detected in 84% (42/50) and 100% (50/50) of the isolates, respectively (Figure 3).

Figure 3

3.4 Distribution of virulence-associated genes

A total of 17 virulence-associated genes were identified among the isolates, and the results are summarized in Figure 4A. Virulence genes with detection rates exceeding 80% included the adhesin-related genes aatA (86%, 43/50) and mat (84%, 42/50); the invasion-related genes ibeB (100%, 50/50) and yijP (86%, 43/50); the serum survival–associated gene ompA (100%, 50/50); and the iron acquisition gene iucD (84%, 42/50). In addition, the adhesin-related gene fimC (78%, 39/50); the serum resistance–associated genes iss (62%, 31/50) and iroN (74%, 37/50); and the iron transport–related genes fyuA (60%, 30/50) and irp2 (68%, 34/50) showed detection rates above 60%. In contrast, relatively low detection rates were observed for papC (4%, 2/50), tsh (32%, 16/50), vat (10%, 5/50), ibeA (4%, 2/50), neuC (10%, 5/50), and cva (12%, 6/50). The distribution of the six virulence genes with detection rates above 80% was further compared among E. coli isolates with different biofilm-forming capacities (Figure 4B). The genes aatA, mat, ibeB, yijP, ompA, and iucD were most frequently detected in strong biofilm-forming isolates, with proportions exceeding 46%. Moderate biofilm-forming isolates showed intermediate detection rates, ranging from 28 to 36%. In contrast, weak or non-biofilm-forming isolates exhibited similarly low detection rates for these six genes, ranging from 2 to 6%. These results indicate that, among mcr-1-positive isolates, stronger biofilm-forming ability is associated with a higher likelihood of carrying these virulence genes.

Figure 4

3.5 Assessment of biofilm-forming capacity

The biofilm-forming ability of 50 mcr-1-positive APEC isolates was evaluated using the crystal violet staining assay. The results showed that 96% (48/50) of the isolates were capable of forming biofilms. Among them, strong biofilm formation was observed in 54% (27/50) of the isolates, whereas moderate and weak biofilm formation accounted for 36% (18/50) and 6% (3/50), respectively. Only 4% (2/50) of the isolates were classified as non-biofilm formers (Figure 5). These results indicate that mcr-1-positive isolates generally exhibit a strong capacity for biofilm formation.

Figure 5

3.6 Correlation between biofilm formation and resistance or virulence genes

To evaluate the relationship between biofilm formation and resistance or virulence genes, correlation analyses were performed. As shown in Figure 6A, the absolute correlation coefficients (|r|, p > 0.05) between resistance genes and biofilm formation were all below 0.1, suggesting no correlation. Similarly, virulence-associated genes, in general, showed no association with biofilm formation. However, as shown in Figure 6B, the ibeA exhibited a moderate negative correlation with biofilm formation capacity (r = −0.37, p > 0.05), indicating a potential inhibitory effect on biofilm formation.

Figure 6

4 Discussion

Polymyxin antibiotics play a critical role in both human medicine and agriculture. However, expression of the resistance gene mcr-1 leads to modification of lipid A on the bacterial outer membrane, thereby reducing its affinity for polymyxins (Khondker and Rheinstädter, 2020). Previous studies reported that, among 91 E. coli isolates recovered from laying hens, broilers, pullets, and turkeys, phenotypic assays combined with genetic analysis (mcr-1) identified a resistance rate of 22% (Stępień-Pyśniak et al., 2025). Of particular concern, this gene can be readily disseminated among different bacterial strains via conjugative horizontal gene transfer, resulting in the widespread and unavoidable emergence of polymyxin resistance, which ultimately poses a serious threat to both animal and human health (Khondker and Rheinstädter, 2020; Rodríguez-Santiago et al., 2021). Therefore, the present study systematically characterized the molecular epidemiological features of 50 mcr-1-positive APEC isolates from Shanxi Province, China.

In APEC-associated infections, serogroups O1, O2, O18, O78, and O145 are among the most frequently reported (Tan et al., 2024; Runcharoon et al., 2025). Consistent with previous findings, the common pathogenic serogroups O18 and O78 showed high detection rates in the present study. In contrast, the absence of serogroup O1 may reflect regional or host-related differences. Most APEC strains belong to phylogenetic groups associated with ExPEC. Based on studies of clonal population structure, E. coli has been classified into four major phylogenetic groups (A, B1, B2, and D) (Jamali et al., 2024). Ewers et al. (2007) demonstrated, using the E. coli reference collection (ECOR), that human ExPEC isolates predominantly belong to phylogroup B2, followed by phylogroup D. Although a considerable proportion of APEC isolates were also assigned to phylogroup B2 (35.1%), a larger proportion (46.1%) belonged to phylogroup A. These observations are consistent with our findings and suggest that the isolates analyzed in this study may be better adapted to environmental niches or avian hosts rather than representing typical human-pathogenic lineages. Notably, 34% of the mcr-1-positive isolates in this study could not be assigned to the established E. coli phylogenetic group. This may reflect limitations of the PCR-based phylogenetic classification scheme, particularly for APEC strains carrying mobile resistance elements such as mcr-1. Further studies employing multiplex PCR approaches are needed to determine whether these isolates belong to additional phylogenetic lineages, including groups C, E, and F (Tohmaz et al., 2022). We acknowledge that the use of the original Clermont triplex method represents a limitation of this study, as it does not distinguish several phylogroups recognised in updated classification schemes. Future studies employing whole-genome sequencing will be necessary to more accurately define the phylogenetic background of these strains.

Sub-therapeutic doses of antibiotics have long been used in poultry feed to prevent and control infections, which has contributed to the increasing prevalence of multidrug-resistant APEC strains (Forgetta et al., 2012). In the present study, all 50 mcr-1-positive isolates were identified as multidrug resistant, highlighting the urgent need for effective control strategies against APEC. Azam et al. performed whole-genome sequencing on 75 APEC isolates recovered from colibacillosis-affected broilers in Pakistan and reported that 89.3% of the isolates carried genes predicted to confer resistance to aminoglycosides, tetracyclines, and sulfonamides (Azam et al., 2020). Consistent with these findings, the mcr-1-positive isolates in this study exhibited high resistance to most antimicrobial classes, with only a small proportion showing resistance to ceftazidime and ofloxacin, and no resistance to amikacin. Moreover, the observed resistance phenotypes were highly consistent with the presence of resistance genes (tetA, blaTEM, aphA, and sul2), suggesting that the underlying resistance mechanisms are well defined and relatively stable. Plasmids are extrachromosomal genetic elements and serve as highly efficient vehicles for the horizontal transfer of antimicrobial resistance genes. IncF plasmids, in particular, have been associated with a wide range of resistance determinants targeting clinically important antimicrobials, including quinolones, β-lactams, tetracyclines, sulfonamides, chloramphenicol, and aminoglycosides (Yoon et al., 2020). In this study, most resistance genes coexisting with mcr-1 were plasmid mediated, implying the potential involvement of co-selection or co-dissemination mechanisms.

Wang et al. constructed an ibeB mutant of the DE205B strain and demonstrated that ibeB is involved in APEC invasion and virulence (Wang et al., 2012). OmpA is a key surface structure that enables bacteria to evade complement-mediated killing during the early stages of infection. E. coli K1 can enter neutrophils and macrophages in an OmpA-dependent manner, thereby downregulating the bactericidal functions of these immune cells (Krishnan et al., 2015). In the present study, the ibeB and ompA genes were detected in all mcr-1-positive isolates, indicating that these strains possess strong invasive potential and an enhanced ability to evade host immune defenses.

Biofilms are complex and protective microbial communities that play a critical role in the bacterial life cycle. These structures promote bacterial survival and enhance resistance to environmental stresses, including antibiotic exposure (Wang et al., 2023). In the present study, 96% of the mcr-1-positive isolates were capable of forming biofilms, indicating that biofilm formation represents a common and important survival strategy among these strains. We further analysis of the association between biofilm formation and antimicrobial resistance or virulence genes revealed that the majority showed no correlation (|r| < 0.1). Interestingly, a moderate negative correlation was observed between the ibeA and biofilm formation (r = −0.37), which appears to contrast with previous findings in the AAEC189 strain, where ibeA was reported to enhance biofilm formation (Wang et al., 2011). This discrepancy may be attributable to substantial differences in the genetic backgrounds of the strains examined. In addition, we found that isolates with strong biofilm-forming capacity exhibited higher carriage rates of virulence genes, suggesting that virulence and environmental adaptability may have co-evolved. Although the correlation analysis revealed no association between biofilm formation and the majority of individual virulence genes, isolates with strong biofilm-forming ability showed a higher cumulative prevalence of multiple virulence factors. These findings suggest that biofilm formation may be associated with pathogenicity at the population level and is likely regulated by multifactorial mechanisms rather than by single-gene effects, warranting further mechanistic investigations.

Several limitations of this study should be acknowledged. First, the isolates analyzed were collected exclusively from Shanxi Province, China, which may limit the generalizability of the findings. Second, whole-genome sequencing was not performed, and therefore novel resistance or virulence genes, as well as detailed plasmid architectures, may have been overlooked. Third, although the resistance phenotypes observed were generally consistent with the detected resistance genes, we acknowledge that other untested resistance mechanisms may also contribute to the phenotypic profiles, as the resistance gene panel investigated was limited. Fourth, we did not examine the genetic context of mcr-1, such as plasmid replicon types, transferability, or chromosomal versus plasmid location. These aspects are important for understanding the dissemination of colistin resistance and should be addressed in future studies. In addition, biofilm formation was assessed using an in vitro model, which may not fully reflect conditions in vivo.

In conclusion, this study demonstrates that mcr-1-positive APEC isolates in Shanxi Province, China, exhibit high levels of antimicrobial resistance, possess considerable pathogenic potential, and display a broad capacity for biofilm formation. These findings provide baseline data for understanding the local epidemiology of mcr-1-positive APEC in this region. However, as the isolates were collected from a single province, the broader epidemiological significance beyond this area remains to be determined.

By providing baseline data from a key agricultural region in China, our study contributes to the global surveillance of mcr-1 and enhances our understanding of the epidemiology of mcr-1-positive APEC. Future nationwide surveillance, preferably combined with whole-genome analyses, is needed to better assess the distribution and dissemination of these strains. Moreover, strengthened regulation of veterinary antibiotic use is urgently needed to prevent the transmission of resistance genes through the food chain to humans. These findings highlight the need for continued surveillance and coordinated strategies to monitor colistin resistance in poultry production.

Statements

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Author contributions

LF: Conceptualization, Formal analysis, Funding acquisition, Investigation, Writing – original draft, Writing – review & editing. WHaly: Data curation, Formal analysis, Writing – original draft. SP: Writing – original draft. WJ: Conceptualization, Writing – review & editing. HJ: Writing – original draft. LL: Writing – original draft. WZ: Writing – original draft. SN: Writing – review & editing. BY: Writing – original draft. HX: Conceptualization, Formal analysis, Resources, Supervision, Writing – review & editing. WHaid: Conceptualization, Formal analysis, Resources, Supervision, Writing – review & editing.

Funding

The author(s) declared that financial support was received for this work and/or its publication. This research was supported by the National Natural Science Foundation of China (grant no. U22A20518); the Central Guided for Local Science and Technology Development Funds (grant no. 2022 L3067); the Open Fund of the Fujian Provincial Key Laboratory of Preventive Veterinary Medicine and Biotechnology (Longyan University) (grant no. 2025KF03); the Scientific and Technological Innovation Enhancement Project of Shanxi Agricultural University (grant no. CXGC2025010); the Fund opened from Key Laboratory of Fujian Universities Preventive Veterinary Medicine and Biotechnology, Longyan University (grant no. 2021KF01); and the Start-up Fund for Doctoral Research at Shanxi Agricultural University (grant no. 2026BQ07).

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that Generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2026.1883400/full#supplementary-material

References

  • 1

    AzamM.MohsinM.JohnsonT. J.SmithE. A.JohnsonA.UmairM.et al. (2020). Genomic landscape of multi-drug resistant avian pathogenic Escherichia coli recovered from broilers. Vet. Microbiol.247:108766. doi: 10.1016/j.vetmic.2020.108766

  • 2

    CarradoriS.Di GiacomoN.LobefaloM.LuisiG.CampestreC.SistoF. (2020). Biofilm and quorum sensing inhibitors: the road so far. Expert Opin. Ther. Pat.30, 917930. doi: 10.1080/13543776.2020.1830059,

  • 3

    ClermontO.BonacorsiS.BingenE. (2000). Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol.66, 45554558. doi: 10.1128/AEM.66.10.4555-4558.2000,

  • 4

    EwersC.LiG.WilkingH.KiesslingS.AltK.AntáoE. M.et al. (2007). Avian pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli: how closely related are they?Int J Med Microbiol297, 163176. doi: 10.1016/j.ijmm.2007.01.003,

  • 5

    FancherC. A.ThamesH. T.ColvinM. G.SmithM.EasterlingA.NuthalapatiN.et al. (2021). Prevalence and molecular characteristics of avian pathogenic Escherichia coli in “no antibiotics ever” broiler farms. Microbiol. Spectrum9:e0083421. doi: 10.1128/Spectrum.00834-21,

  • 6

    FengA.AkterS.LeighS. A.WangH.PharrG. T.EvansJ.et al. (2023). Genomic diversity, pathogenicity and antimicrobial resistance of Escherichia coli isolated from poultry in the southern United States. BMC Microbiol.23:15. doi: 10.1186/s12866-022-02721-9,

  • 7

    ForgettaV.RempelH.MalouinF.VaillancourtR.Jr.ToppE.DewarK.et al. (2012). Pathogenic and multidrug-resistant Escherichia fergusonii from broiler chicken. Poult. Sci.91, 512525. doi: 10.3382/ps.2011-01738,

  • 8

    FuD.WuJ.WuX.ShaoY.SongX.TuJ.et al. (2023). The two-component system histidine kinase EnvZ contributes to avian pathogenic Escherichia coli pathogenicity by regulating biofilm formation and stress responses. Poult. Sci.102:102388. doi: 10.1016/j.psj.2022.102388,

  • 9

    HabouriaH.PokharelP.MarisS.GarénauxA.BessaiahH.HouleS.et al. (2019). Three new serine-protease autotransporters of Enterobacteriaceae (SPATEs) from extra-intestinal pathogenic Escherichia coli and combined role of SPATEs for cytotoxicity and colonization of the mouse kidney. Virulence10, 568587. doi: 10.1080/21505594.2019.1624102,

  • 10

    HaiP. V.HoaN. X.PhuongH. T. A. (2025). Fermented purple onion (Allium cepa L.) and chive (Allium schoenoprasum) bulb extracts as antibiotic alternatives against toxin-carrying bacteria: in vitro and pathogenicity assessment in chickens. Open Vet J15, 23552364. doi: 10.5455/OVJ.2025.v15.i6.8,

  • 11

    HuJ.GuY.LuH.RaheemM. A.YuF.NiuX.et al. (2022). Identification of novel biofilm genes in avian pathogenic Escherichia coli by Tn5 transposon mutant library. World J Microbiol Biotechnol38:130. doi: 10.1007/s11274-022-03314-4,

  • 12

    IdreesM.SawantS.KarodiaN.RahmanA. (2021). Staphylococcus aureus biofilm: morphology, genetics, pathogenesis and treatment strategies. Int. J. Environ. Res. Public Health18:7602. doi: 10.3390/ijerph18147602,

  • 13

    JamaliH.AkramiF.BouakkazS.DozoisC. M. (2024). Prevalence of specific serogroups, antibiotic resistance and virulence factors of avian pathogenic Escherichia coli (APEC) isolated from clinical cases: a systematic review and meta-analysis. Microb. Pathog.194:106843. doi: 10.1016/j.micpath.2024.106843,

  • 14

    JohnsonT. J.MillerE. A.Flores-FigueroaC.Munoz-AguayoJ.CardonaC.FransenK.et al. (2022). Refining the definition of the avian pathogenic Escherichia coli (APEC) pathotype through inclusion of high-risk clonal groups. Poult. Sci.101:102009. doi: 10.1016/j.psj.2022.102009,

  • 15

    KathayatD.LokeshD.RanjitS.RajashekaraG. (2021). Avian pathogenic Escherichia coli (APEC): an overview of virulence and pathogenesis factors, zoonotic potential, and control strategies. Pathogens10:467. doi: 10.3390/pathogens10040467,

  • 16

    KhondkerA.RheinstädterM. C. (2020). How do bacterial membranes resist polymyxin antibiotics?Commun Biol3:77. doi: 10.1038/s42003-020-0803-x,

  • 17

    KrishnanS.ChangA. C.HodgesJ.CouraudP. O.RomeroI. A.WekslerB.et al. (2015). Serotype O18 avian pathogenic and neonatal meningitis Escherichia coli strains employ similar pathogenic strategies for the onset of meningitis. Virulence6, 777786. doi: 10.1080/21505594.2015.1091914,

  • 18

    LiF.LiM.NieL.ZuoJ.FanW.LianL.et al. (2021). Molecular epidemiology and antibiotic resistance associated with avian pathogenic Escherichia coli in Shanxi Province, China, from 2021 to 2023. Microorganisms13:541. doi: 10.3390/microorganisms13030541,

  • 19

    LiangL.LiY.WangL.WangW.ZhangY.ZhaoH.et al. (2025). Fitness costs of mobilised colistin resistance gene 3 (mcr-3): systematic review, epidemiological study, and functional analysis. EBioMedicine120:105923. doi: 10.1016/j.ebiom.2025.105923,

  • 20

    NangS. C.LiJ.VelkovT. (2019). The rise and spread of mcr plasmid-mediated polymyxin resistance. Crit. Rev. Microbiol.45, 131161. doi: 10.1080/1040841X.2018.1492902,

  • 21

    NawazS.WangZ.ZhangY.JiaY.JiangW.ChenZ.et al. (2024). Avian pathogenic Escherichia coli (APEC): current insights and future challenges. Poult. Sci.103:104359. doi: 10.1016/j.psj.2024.104359,

  • 22

    NgaiD. G.NyamacheA. K.OmboriO. (2021). Prevalence and antimicrobial resistance profiles of Salmonella species and Escherichia coli isolates from poultry feeds in Ruiru Sub-County, Kenya. BMC. Res. Notes14:41. doi: 10.1186/s13104-021-05456-4,

  • 23

    QuaresmaA.RodriguesY. C.AboimJ. B.BezerraM. M.GouveiaM. I. M.Da CostaA. R. F.et al. (2022). Molecular epidemiology of sporadic and outbreak-related Salmonella typhi isolates in the Brazilian north region: a retrospective analysis from 1995 to 2013. Infect. Dis. Rep.14, 569573. doi: 10.3390/idr14040060

  • 24

    RamalokoW. T.Osei SekyereJ. (2022). Phylogenomics, epigenomics, virulome and mobilome of gram-negative bacteria co-resistant to carbapenems and polymyxins: a one health systematic review and meta-analyses. Environ. Microbiol.24, 15181542. doi: 10.1111/1462-2920.15930,

  • 25

    Rodríguez-SantiagoJ.Cornejo-JuárezP.Silva-SánchezJ.Garza-RamosU. (2021). Polymyxin resistance in Enterobacterales: overview and epidemiology in the Americas. Int. J. Antimicrob. Agents58:106426. doi: 10.1016/j.ijantimicag.2021.106426,

  • 26

    RuncharoonK.GarciaB.PetersonB. N.YoungM. M.FavroM. E.BarbieriN. L.et al. (2025). Longitudinal study of avian pathogenic Escherichia coli (APEC) serogroups associated with disease in Georgia poultry using molecular serology and virulence gene analysis. Avian Pathol54, 185197. doi: 10.1080/03079457.2024.2403414,

  • 27

    SeiffertS. N.HiltyM.PerretenV.EndimianiA. (2013). Extended-spectrum cephalosporin-resistant gram-negative organisms in livestock: an emerging problem for human health?Drug Resist Updat16, 2245. doi: 10.1016/j.drup.2012.12.001,

  • 28

    ShoaibM.HameedM. F.AqibA. I.WangW.WangQ.WangS.et al. (2025). Emerging threat of antimicrobial resistance determinants and plasmid replicon types acquisition by Escherichia coli of poultry and other food-producing animal origin in China: local findings with global implications. Poult. Sci.104:106055. doi: 10.1016/j.psj.2025.106055,

  • 29

    Stępień-PyśniakD.HauschildT.ŁopuckiR.KosikowskaU.WilczyńskiJ.BrzeskiM.et al. (2025). Differences in tests of phenotypic colistin resistance in clinical Escherichia coli isolates from poultry and their genetic diversity. Vet. Microbiol.307:110581. doi: 10.1016/j.vetmic.2025.110581,

  • 30

    TanM. F.TanJ.FangS. P.KangZ. F.LiH. Q.ZhangF. F.et al. (2024). Pathogenicity and identification of host adaptation genes of the avian pathogenic Escherichia coli O145 in duck. Front. Cell. Infect. Microbiol.14:1453907. doi: 10.3389/fcimb.2024.1453907,

  • 31

    ThomrongsuwannakijT.BlackallP. J.DjordjevicS. P.CumminsM. L.ChansiripornchaiN. (2020). A comparison of virulence genes, antimicrobial resistance profiles and genetic diversity of avian pathogenic Escherichia coli (APEC) isolates from broilers and broiler breeders in Thailand and Australia. Avian Pathol.49, 457466. doi: 10.1080/03079457.2020.1764493,

  • 32

    TohmazM.Askari BadoueiM.Kalateh RahmaniH.Hashemi TabarG. (2022). Antimicrobial resistance, virulence associated genes and phylogenetic background versus plasmid replicon types: the possible associations in avian pathogenic Escherichia coli (APEC). BMC Vet. Res.18:421. doi: 10.1186/s12917-022-03496-x,

  • 33

    WangZ.ChenR.XiaF.JiangM.ZhuD.ZhangY.et al. (2023). ProQ binding to small RNA RyfA promotes virulence and biofilm formation in avian pathogenic Escherichia coli. Vet. Res.54:109. doi: 10.1186/s13567-023-01241-2,

  • 34

    WangS.NiuC.ShiZ.XiaY.YaqoobM.DaiJ.et al. (2011). Effects of ibeA deletion on virulence and biofilm formation of avian pathogenic Escherichia coli. Infect. Immun.79, 279287. doi: 10.1128/IAI.00821-10,

  • 35

    WangS.ShiZ.XiaY.LiH.KouY.BaoY.et al. (2012). IbeB is involved in the invasion and pathogenicity of avian pathogenic Escherichia coli. Vet. Microbiol.159, 411419. doi: 10.1016/j.vetmic.2012.04.015,

  • 36

    WangX.SunY.SubediD.GongQ.HuangH.LiJ.et al. (2022). Hcp proteins of the type VI secretion system promote avian pathogenic E. coli DE205B (O2:K1) to induce meningitis in rats. Life12:1353. doi: 10.3390/life12091353,

  • 37

    YinL.ChengB.TuJ.ShaoY.SongX.PanX.et al. (2022). YqeH contributes to avian pathogenic Escherichia coli pathogenicity by regulating motility, biofilm formation, and virulence. Vet. Res.53:30. doi: 10.1186/s13567-022-01049-6,

  • 38

    YoonM. Y.KimY. B.HaJ. S.SeoK. W.NohE. B.SonS. H.et al. (2020). Molecular characteristics of fluoroquinolone-resistant avian pathogenic Escherichia coli isolated from broiler chickens. Poult. Sci.99, 36283636. doi: 10.1016/j.psj.2020.03.029,

  • 39

    ZhaoX.ZhaoH.ZhouZ.MiaoY.LiR.YangB.et al. (2022). Characterization of extended-Spectrum β-lactamase-producing Escherichia coli isolates that cause Diarrhea in sheep in Northwest China. Microbiol. Spectrum10:e0159522. doi: 10.1128/spectrum.01595-22,

Summary

Keywords

avian pathogenic Escherichia coli, biofilm formation, MCR-1, molecular epidemiology, multidrug resistance

Citation

Fangfang L, Haiyang W, Pengju S, Jingying W, Jiangang H, Liyan L, Zhihao W, Nawaz S, Yinli B, Xiangan H and Haidong W (2026) Molecular epidemiology of mcr-1-harboring avian pathogenic Escherichia coli from diseased chickens in Shanxi, China (2021–2024). Front. Microbiol. 17:1883400. doi: 10.3389/fmicb.2026.1883400

Received

17 May 2026

Revised

24 June 2026

Accepted

29 June 2026

Published

11 August 2026

Volume

17 - 2026

Edited by

Fábio Sellera, Universidade Metropolitana de Santos, Brazil

Reviewed by

Antonia Mataragka, Agricultural University of Athens, Greece

Tiago Lima, University of Évora, Portugal

Updates

Copyright

*Correspondence: Wang Haidong, ;

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics